Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma | Zendy

Sam H. Ahmedzai | Zendy; John A. Snowden | Zendy; A. John Ashcroft | Zendy; David A. Cairns | Zendy; Cathy Williams | Zendy; Anna Hockaday | Zendy; Jamie Cavenagh | Zendy; Debo Ademokun | Zendy; Eleni Tholouli | Zendy; David Allotey | Zendy; Vijay Dhanapal | Zendy; Matthew Jenner | Zendy; Kwee Yong | Zendy; Jim Cavet | Zendy; Hannah Hunter | Zendy; Jennifer M. Bird | Zendy; Guy Pratt | Zendy; Christopher Parrish | Zendy; Julia Brown | Zendy; T. C. M. Morris | Zendy; Gordon Cook | Zendy

Open Access

Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma

Author(s) -

Sam H. Ahmedzai,

John A. Snowden,

A. John Ashcroft,

David A. Cairns,

Cathy Williams,

Anna Hockaday,

Jamie Cavenagh,

Debo Ademokun,

Eleni Tholouli,

David Allotey,

Vijay Dhanapal,

Matthew Jenner,

Kwee Yong,

Jim Cavet,

Hannah Hunter,

Jennifer M. Bird,

Guy Pratt,

Christopher Parrish,

Julia Brown,

T. C. M. Morris,

Gordon Cook

Publication year - 2019

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.18.01006

Subject(s) - medicine , multiple myeloma , quality of life (healthcare) , adverse effect , transplantation , autologous stem cell transplantation , brief pain inventory , randomized controlled trial , clinical trial , surgery , physical therapy , chronic pain , nursing

Salvage autologous stem-cell transplantation (sASCT) in patients with multiple myeloma (MM) relapsing after a prior autologous stem-cell transplantation leads to increased remission duration and overall survival. We report a comprehensive study on patient-reported outcomes, including quality of life (QoL) and pain in sASCT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research